Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Trends in Molecular Medicine|June 14, 2005
Emerging therapeutic approaches for osteogenesis imperfectaSophia Millington-Ward, Helena P McMahon, G Jane Farrar
Trends in Genetics : TIG|June 13, 2013
Mitochondrial disorders: aetiologies, models systems, and candidate therapiesG Jane Farrar, Naomi Chadderton, Paul F Kenna, et al.
Advances in Experimental Medicine and Biology|December 30, 2019
Retinal Bioenergetics: New Insights for TherapeuticsDaniel M Maloney, Naomi Chadderton, Arpad Palfi, et al.
Visual Neuroscience|June 21, 2014
Gene therapies for inherited retinal disordersG Jane Farrar, Sophia Millington-Ward, Naomi Chadderton, et al.
Investigative Ophthalmology & Visual Science|October 31, 2002
Sensitivity of photoreceptor-derived cell line (661W) to baculoviral p35, Z-VAD.FMK, and Fas-associated death domainGearóid Tuohy, Sophia Millington-Ward, Paul F Kenna, et al.
Molecular Therapy. Methods & Clinical Development|April 27, 2022
AAV-PHP.eB transduces both the inner and outer retina with high efficacy in miceArpad Palfi, Naomi Chadderton, Sophia Millington-Ward, et al.
Frontiers in Neuroscience|September 25, 2020
AAV-Delivered <i>Tulp1</i> Supplementation Therapy Targeting Photoreceptors Provides Minimal Benefit in <i>Tulp1-/-</i> RetinasArpad Palfi, Adlet Yesmambetov, Sophia Millington-Ward, et al.
The Journal of Gene Medicine|April 3, 2007
Development of strategies for conditional RNA interferenceDanny Allen, Paul F Kenna, Arpad Palfi, et al.
Frontiers in Neuroscience|October 7, 2017
A Novel Retinal Ganglion Cell Promoter for Utility in AAV VectorsKillian S Hanlon, Naomi Chadderton, Arpad Palfi, et al.
International Journal of Molecular Sciences|February 15, 2022
SARM1 Ablation Is Protective and Preserves Spatial Vision in an In Vivo Mouse Model of Retinal Ganglion Cell DegenerationLaura K Finnegan, Naomi Chadderton, Paul F Kenna, et al.
Pageof 4